Search results
Showing 721 to 735 of 8398 results
Dexamethasone and hydrocortisone are both corticosteroids; they have a role in treating COVID-19 in certain people.
All NICE products on suicide prevention. Includes any guidance and quality standards.
All NICE products on infectious disease prevention and control. Includes any guidance, advice and quality standards.
All NICE products on accident and injury prevention. Includes any guidance, advice and quality standards.
All NICE products on lymphoedema. Includes any guidance and advice.
All NICE products on vaginal conditions. Includes any guidance.
All NICE products on mesothelioma. Includes any guidance.
All NICE products on maxillofacial conditions. Includes any guidance.
All NICE products on gastroparesis. Includes any guidance and advice.
All NICE products on diabetes. Includes any guidance, advice and quality standards.
This quality standard covers diagnosing and managing renal cell carcinoma in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.
View quality statements for QS215Show all sections
Sections for QS215
- Quality statements
- Quality statement 1: Suspected cancer pathway referral
- Quality statement 2: Renal biopsy for small renal lesions
- Quality statement 3: Clinical nurse specialist
- Quality statement 4: Surgery with curative intent
- Quality statement 5: Follow-up imaging
- Quality statement 6: Uro–oncology multidisciplinary team
- About this quality standard
This quality standard covers the diagnosis and initial management of ectopic pregnancy and miscarriage in women in their first trimester (up to 13 completed weeks of pregnancy). It includes assessment and diagnosis for women with suspected early pregnancy loss. It describes high-quality care in priority areas for improvement.
View quality statements for QS69Show all sections
All NICE products on parathyroid disorders. Includes any guidance.
This quality standard covers the diagnosis and management of cataracts, glaucoma and age-related macular degeneration (AMD) and the prevention of sight loss. It describes high-quality care in priority areas for improvement.
View quality statements for QS180Show all sections
Sections for QS180
- Quality statements
- Quality statement 1: Referral – chronic open angle glaucoma and related conditions
- Quality statement 2: Referral for cataract surgery
- Quality statement 3: Treatment – late age-related macular degeneration (wet active)
- Quality statement 4: Monitoring late age-related macular degeneration (wet active)
- Quality statement 5: Reassessment – chronic open angle glaucoma or related conditions
- Quality statement 6: Certificate of vision impairment
- Update information
Mitapivat for treating pyruvate kinase deficiency (terminated appraisal) (TA867)
NICE is unable to make a recommendation on mitapivat (Pyrukynd) for treating pyruvate kinase deficiency in adults because Agios did not provide an evidence submission. We will review this decision if the company decides to make a submission.
Show all sections
Sections for TA867